Bharat Forge Shares Hit 52-Week High After Q4, Brokerages Upbeat on Defence, Exports

Why It Matters

The results underscore Bharat Forge’s expanding role in India’s defence and export‑driven manufacturing, influencing investor sentiment and sector dynamics. Strong top‑line growth and upbeat broker outlook could spur further capital inflows into Indian industrial stocks.

Key Takeaways

• Revenue rose 17.5% YoY to ₹4,528 crore (~$545 M)
• EBITDA increased to ₹774 crore (~$93 M), beating standalone expectations
• Shares touched ₹2,044 (~$24.6), a 52‑week high
• Brokers raise target prices, citing defence and export growth
• Valuations remain a concern despite revenue acceleration

Pulse Analysis

Bharat Forge, one of India’s largest forging and machining firms, posted a robust Q4 FY26 performance that resonated across the market. Revenue climbed to ₹4,528 crore, roughly $545 million, while EBITDA reached ₹774 crore (about $93 million), reflecting a 17.5% year‑on‑year increase. The surge was anchored by higher export volumes and operational efficiencies across its defence, aerospace and automotive casting divisions. The stock’s brief ascent to a 52‑week high of ₹2,044 ($24.6) signals renewed investor confidence in the company’s growth trajectory.

The upside is largely attributed to macro‑level tailwinds. A recent GST rate cut has revived domestic auto demand, while the US Class 8 truck market appears to be bottoming out, offering a potential export lift. Defence spending in India is on an upward trajectory, and Bharat Forge’s strategic positioning in aerospace and defence manufacturing aligns with government initiatives to boost indigenous capabilities. Analysts at Jefferies and Morgan Stanley have upgraded earnings estimates, projecting a 42% EPS compound annual growth rate through FY28, driven by these sectors.

Despite the optimism, brokerages remain cautious on valuation. Citi and Kotak Securities maintain sell or neutral stances, citing that much of the upside may already be priced in after the recent rally. The company also faces a standalone loss due to an impairment charge in its CDP business, and restructuring timelines extend into 2027. Investors should weigh the strong export and defence fundamentals against valuation premiums and execution risks before adding Bharat Forge to their portfolios.